Replies to post #173902 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Another Anavex CNS competitor reliably flunks again!

“Axovant's nelotanserin flunks mid-stage study, shares down 27% premarket”
https://seekingalpha.com/news/3415568

At some point an award for last one still standing will be given to AVXL, PM at it's finest hour. IMO.

[tredenwater2]

Oh me Oh my how are they going to recover. Time to bring in another "high profile" CEO to create a distraction for shareholders...."Hey forget that, looky over here!"

All hype and no good news. Hmm and why is it we are chastised for doing the exact opposite? Anyday, week, month.

Tred

[bas2020]

Didn't we see this coming... again?!